UNIGE document Scientific Article
previous document  unige:89078  next document
add to browser collection
Title

Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy

Authors
Wiggins, K L
Harrington, L B
Psaty, B M
Smith, N L
Published in Journal of Thrombosis and Haemostasis. 2013, vol. 11, no. 8, p. 1617-1619
Keywords ABO Blood-Group System/metabolismAdministration, OralAgedAllelesCase-Control StudiesCytochrome P-450 CYP3A/metabolismFemaleGene FrequencyGenetic VariationHormones/administration & dosageHumansMiddle AgedNF-E2-Related Factor 2/metabolismPolymorphism, Single NucleotidePostmenopausePulmonary Embolism/bloodRegression AnalysisRisk FactorsVenous Thrombosis/bloodWashington
Identifiers
PMID: 23734777
Full text
Article (Published version) (76 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group La maladie thromboembolique veineuse (808)
Citation
(ISO format)
BLONDON, Marc et al. Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy. In: Journal of Thrombosis and Haemostasis, 2013, vol. 11, n° 8, p. 1617-1619. https://archive-ouverte.unige.ch/unige:89078

25 hits

0 download

Update

Deposited on : 2016-11-18

Export document
Format :
Citation style :